packageInotuzumabOzogamicin

inotuzumab ozogamicin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Inotuzumab ozogamicin is an antibody-drug conjugate used to treat a form of acute lymphoblastic leukemia/lymphoma. It is authorised in the European Union and carries a boxed warning, so its use is closely monitored.

Summary written by glm-5.3-flash from Wikidata Q3799041 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:inotuzumab ozogamicin
ATC codes:L01FB01
DrugBank:DB05889
Wikidata:Q3799041

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown